SOX2-OT and glioblastoma: SOX2OT is significantly upregulated in GSCs and glioblastoma tissues, and decreased expression levels of SOX2OT impede the malignant biological activities of GSCs by elevating miR-194-5p and miR-122 levels (Su et al., 2017).